Detail akcie Tristel online

Business Summary: Tristel plc is a United Kingdom-based infection prevention company. The Company's core business is the sale to hospitals of its chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand, and for the sporicidal disinfection of environmental surfaces under the Cache brand. The Company operates through three segments: Hospital medical device decontamination, Hospital environmental surface disinfection and others. It manufactures and sells medical device decontamination products which are used primarily for infection control in hospitals. The Company also manufactures and sells hospital environmental surface disinfection products. It addresses pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare sectors. The Tristel brand offers airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal (GI) physiology, laboratory, ophthalmology, and ultrasound.
Financial Summary: BRIEF: For the fiscal year ended 30 June 2025, Tristel Plc revenues increased 11% to L46.5M. Net income increased 2% to L6.6M. Revenues reflect Hospital medical device segment increase of 11% to L40.4M, Hospital environmental surface segment increase of 7% to L3.7M, UK to UK and oversease distriributors segment increase of 10% to L21.9M, World segment increase of 28% to L6.1M. Net income was partially offset by Other SGA increase of 8% to L24.6M (expense).